Literature DB >> 25210021

Reply to Worth et al.

Brett G Mitchell1, Peter J Collignon2, Rebecca McCann3, Irene J Wilkinson4, Anne Wells5.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25210021      PMCID: PMC4243700          DOI: 10.1093/cid/ciu692

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
To the Editor—We thank Worth and colleagues [1] for reflecting on some important points related to our recent study where we reported a 63% reduction in hospital-onset (HO) Staphylococcus aureus bacteremia (SAB) in Australia [2]. We agree that the HO-SAB definition used in our study is not the national definition currently used for healthcare-associated (HCA) SAB surveillance in Australian hospitals. We commented on this in the discussion. Authors of our study have previously made similar comments to those made by Worth and colleagues [3-8]. For the purposes of benchmarking Australia internationally, we believe a HO-SAB definition is a robust and accurate approach to identify any real reduction in SAB—the aim of the paper. Capturing all HCA-SAB cases requires much more additional work by infection control professionals and infectious diseases physicians at a local level. In addition, collecting such additional surveillance requires validation [9, 10], potentially lacking in parts of Australia. However, there are 2 important reasons why we used only a HO-SAB definition in our study. First, we wanted to report data over a long time frame, 12 years of data. The HCA-SAB definition was not agreed upon by Health Ministers until 2008 in Australia, meaning previous longitudinal prospective data were not collected consistently. Retrospective analysis would have been very difficult and likely subject to bias. Second, the HO-SAB definition allows for international comparisons, whereas the HCA-SAB definition does not. Without using a HO-SAB definition, we would not have been able to undertake the comparisons outlined in our discussion. We fully support the use of HCA-SAB surveillance definition and hope that many other countries move to such a definition for the reasons described by Worth and colleagues. We believe that when data are presented, HO-SAB should be presented as a subset of the total HCA-SAB numbers where possible. Comparisons can then be made with studies that have not used the more inclusive definition. The conclusions in our study are consistent with the definitional approach we used. We never stated or implied that we tried to measure and report all cases of HCA-SAB. We acknowledge the point made by Worth and colleagues regarding data analysis and model adjustment for heterogeneity and multistate frailty. We are not convinced that this extra complexity in analysis is needed to demonstrate the points made. Regardless, under the agreements with those providing data for our study, only aggregated hospital data were to be analyzed and published, so the proposed analysis was not possible. What our data showed was a major and significant reduction in incidence of HO-SAB over a 12-year period caused by both methicillin-resistant and methicillin-sensitive S. aureus in Australian hospitals since 2002. This reduction coincided with a range of infection prevention and control activities implemented during this time [2]. It suggests that national and local efforts to reduce the burden have been very successful. As we commented, there are many potential reasons for the reductions in HO-SAB observed in our study, and Worth and colleagues are correct in acknowledging the important role that surveillance and multiple interventions play [11, 12].
  8 in total

1.  Quality of information: a European challenge.

Authors:  Jacques Fabry; Ingrid Morales; Marie-Hélène Metzger; Ian Russell; Petra Gastmeier
Journal:  J Hosp Infect       Date:  2007-06       Impact factor: 3.926

2.  Validation of statewide surveillance system data on central line-associated bloodstream infection in intensive care units in Australia.

Authors:  Emma S McBryde; Judy Brett; Philip L Russo; Leon J Worth; Ann L Bull; Michael J Richards
Journal:  Infect Control Hosp Epidemiol       Date:  2009-11       Impact factor: 3.254

3.  Staphylococcus aureus bacteraemias: time to act.

Authors:  Peter J Collignon; Marilyn Cruickshank
Journal:  Med J Aust       Date:  2009-10-05       Impact factor: 7.738

4.  A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia: a question of definition.

Authors:  Leon J Worth; Tim Spelman; Ann L Bull; Michael J Richards
Journal:  Clin Infect Dis       Date:  2014-09-09       Impact factor: 9.079

5.  Health care-associated Staphylococcus aureus bloodstream infections: a clinical quality indicator for all hospitals.

Authors:  Peter J Collignon; Irene J Wilkinson; Gwendolyn L Gilbert; M Lindsay Grayson; R Michael Whitby
Journal:  Med J Aust       Date:  2006-04-17       Impact factor: 7.738

6.  Intravascular catheter bloodstream infections: an effective and sustained hospital-wide prevention program over 8 years.

Authors:  Peter J Collignon; Dianne E Dreimanis; Wendy D Beckingham; Jan L Roberts; Anne Gardner
Journal:  Med J Aust       Date:  2007-11-19       Impact factor: 7.738

7.  A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia-12 years of progress: an observational study.

Authors:  Brett G Mitchell; Peter J Collignon; Rebecca McCann; Irene J Wilkinson; Anne Wells
Journal:  Clin Infect Dis       Date:  2014-06-27       Impact factor: 9.079

8.  Addressing the need for an infection prevention and control framework that incorporates the role of surveillance: a discussion paper.

Authors:  Brett G Mitchell; Anne Gardner
Journal:  J Adv Nurs       Date:  2013-06-23       Impact factor: 3.187

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.